William B. Horne's most recent trade in Alzamend Neuro Inc was a trade of 3,334 Common Stock done at an average price of $1.0 . Disclosure was reported to the exchange on March 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alzamend Neuro Inc | William B. Horne | Director | Purchase of securities on an exchange or from another person at price $ 0.99 per share. | 26 Mar 2025 | 3,334 | 30,000 | - | 1.0 | 3,285 | Common Stock |
| Alzamend Neuro Inc | William B. Horne | Director | Purchase of securities on an exchange or from another person at price $ 0.98 per share. | 20 Mar 2025 | 5,000 | 26,666 | - | 1.0 | 4,892 | Common Stock |
| Alzamend Neuro Inc | William B. Horne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2025 | 10,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Alzamend Neuro Inc | William B. Horne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.06 per share. | 18 Mar 2025 | 10,000 | 16,666 | - | 0.1 | 600 | Common Stock |
| Alzamend Neuro Inc | William B. Horne | Director | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 18 Mar 2025 | 5,000 | 21,666 | - | 1.0 | 4,852 | Common Stock |
| Alzamend Neuro Inc | William B. Horne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 500,000 | 1,000,000 | - | 0.0 | 2,000 | Common Stock |
| Alzamend Neuro Inc | William B. Horne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 500,000 | 1,500,000 | - | - | Stock Options (Right to Buy) | |
| Alzamend Neuro Inc | William B. Horne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2022 | 250,000 | 2,000,000 | - | - | Stock Options (Right to Buy) | |
| Alzamend Neuro Inc | William B. Horne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2022 | 250,000 | 500,000 | - | 0.0 | 100 | Common Stock |
| Alzamend Neuro Inc | William B. Horne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2022 | 150,000 | 2,250,000 | - | - | Stock Options (Right to Buy) | |
| Alzamend Neuro Inc | William B. Horne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2022 | 150,000 | 250,000 | - | 0.0 | 600 | Common Stock |